|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Structure, function and gene expression of epithelial mucins显示文摘 | Seregni E Botti C Massaron S | 1997 | Tumori1997，83，3： | 2 |
| 2 | Long-term results of suppressing thyroid-stimulating hormone during radiotherapy to prevent primary hypothyroidism in medulloblastoma/PNET and Hodgkin lymphoma:a prospective cohort study显示文摘Primary hypothyroidism commonly occurs after radiotherapy(RT),and coincides with increased circulating thyroid-stimulating hormone(TSH)levels.We tested therefore the protective effect of suppressing TSH with L-thyroxine during RT for medulloblastoma/PNET and Hodgkin lymphoma(HL)in a prospective cohort study.From 1998 to 2001,a total of 37 euthyroid children with medulloblastoma/PNET plus 14 with HL,scheduled for craniospinal irradiation and mediastinum/neck radiotherapy,respectively,underwent thyroid ultrasound and free triiodothyronine(FT3),free thyroxine(FT4),and TSH evaluation at the beginning and end of craniospinal iiradiation.From 14 days before and up to the end of radiotherapy,patients were administered L-thyroxine checking every 3 days TSH to ensure a value<0.3μIU/mL.During follow-up,blood tests and ultrasound were repeated;primary hypothyroidism was considered an increased TSH level greater than normal range.Twenty-two/37 patients with medulloblastoma/PNET and all the 14 patients with HL were alive after a median 231 months from radiotherapy with 7/22 and 8/14 having correctly reached TSH levels˂0.3μIU/mL and well matched for other variables.Twenty years on,hypothyroidism-free survival rates differed significantly,being 60%±15%and 15.6%±8.2%in TSH-suppressed vs.not-TSH suppressed patients,respectively(P=0.001).These findings suggest that hypothyroidism could be durably prevented in two populations at risk of late RT sequelae,but it should be confirmed in a larger cohort. | Maura Massimino Marta Podda Lorenza Gandola Emanuele Pignoli Ettore Seregni Carlo Morosi Filippo Spreafico Andrea Ferrari Emilia Pecori Monica Terenziani | 2021 | Frontiers of Medicine2021，15，1： | 2 |
| 3 | Prognostic Value of Circulating Tumor Markers in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy显示文摘 | Dario Baratti MD Shigeki Kusamura MD PhD Antonia Martinetti MD Ettore Seregni MD Barbara Laterza MD Daniela G. Oliva MD Marcello Deraco MD | 2007 | Annals of Surgical Oncology2007，，8： | 2 |
| 4 | Structure, function and gene expression of epithelial mucins 显示文摘 | Seregni E Botti C Massaron S | 1997 | Tumori1997，83，3： | 1 |
| 5 | Circulating CA125 in Patients with Peritoneal Mesothelioma Treated with Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion显示文摘 | Dario Baratti MD Shigeki Kusamura MD Antonia Martinetti MD Ettore Seregni MD Daniela G. Oliva MD Barbara Laterza MD Marcello Deraco MD | 2007 | Annals of Surgical Oncology2007，，2： | 1 |
| 6 | Immunosuppressive factors: role in cancer development and progression显示文摘 | Botti C Seregni E Ferrari L | 1998 | Int J Biol Markers1998，13，2： | 1 |
| 7 | Diagnostic and therapeutic aspects of iatrogenic hypoparathyroidism 显示文摘 | Pallotti F Seregni E Ferrari L | 2003 | Tumori2003，89，5： | 1 |
| 8 | Structure function and gene expression of epithelial mucins显示文摘 | Seregni E Botti C Massaron S | 1997 | Tumori1997，83，3： | 1 |
| 9 | Clinical utility of biochemical markers of bone remodelling in patients with bone metastases of solid tumors显示文摘 | Martinetti A Ferrari L | 2001 | Q J Nucl Med2001，45，1： | 1 |
| 10 | Pattern of mucin gene expression in normal and neoplastic lung tissues显示文摘 | Seregni E Botti C Lombardo C | 1996 | Anticancer Res1996，16，4： | 1 |
| 11 | Structure, function and gene expression of epithelial mucins 显示文摘 | Seregni E Botti C Massaron S | 1997 | Tumori1997，83，3： | 1 |
| 12 | Immunosuppressive factors: role in cancer development and progression 显示文摘 | Botti C Seregni E Femrri L | 1998 | Int J Biol Markers1998，13，2： | 1 |
| 13 | Circulating tumor marker in breast cancer 显示文摘 | Seregni E Coli A Mazzucca N | 2004 | Eur J Nucl Med Mol Lmaging2004，31，： | 1 |
| 14 | Real-time tumor tracking with an artificial neural networks-based method: a feasibility study显示文摘 | Seregni M Pella A Riboldi M | 2013 | Phys Med2013，29，1： | 1 |
| 15 | Effect of lacidipine on fatty and prolifera-tive lesions induced in hypercholesterolaemic rab- bits显示文摘 | Soma MR Donetti E Seregni R | 1996 | Br J Pharm1996，118，： | 1 |
| 16 | The biological characteristics of chromogranin A and its role of a circulating marker in neuroendocrine tumours 显示文摘 | Ferrari L Seregni E Bajetta E | 1999 | Anticancer Res1999，19，40： | 1 |
| 17 | Structure, function and gene expression of epithelial mucins显示文摘 | Seregni E Botti C Massaron S | 1997 | Tumori1997，83，3： | 1 |
| 18 | The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours显示文摘 | Ferrari L Seregni E Bajetta E | | 0，，： | 1 |
| 19 | Accuracy and clinical correlates of two different methods for chromo- granin A assay in neuroendocrine tumors 显示文摘 | Ferrari L Seregni E Lucignani G | 2004 | Int J Biol Markers2004，19，4： | 1 |
| 20 | Circulating tumor markers in breast cancer显示文摘 | Seregni E Coli A Mazzucca N | 2004 | Eur J Nucl Med Mol Imaging2004，31，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员